Literature DB >> 5536118

Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel.

J J Rahal, R H Meade, C M Bump, A J Reinauer.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5536118

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Aerobic gram-negative pharyngeal bacilli of adult Ethiopians: carrier rates and antibiograms.

Authors:  Y Mengistu; M Gedebou
Journal:  J Hyg (Lond)       Date:  1986-10

Review 2.  The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation.

Authors:  R J Estes; G U Meduri
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

3.  Prevalence of gram-negative bacilli in nares and on hands of pharmacy personnel: lack of effect of occupational exposure to antibiotics.

Authors:  D C Weil; T Chou; P M Arnow
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

4.  Effects of cancer chemotherapy on the human aerobic oropharyngeal flora.

Authors:  K W Renard; M Marling-Cason; R G Sheehan; P A Mackowiak
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

5.  Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1971-12

6.  Isolation of Klebsielleae from within living wood.

Authors:  S T Bagley; R J Seidler; H W Talbot; J E Morrow
Journal:  Appl Environ Microbiol       Date:  1978-07       Impact factor: 4.792

7.  Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients.

Authors:  D E Woods; J A Bass; W G Johanson; D C Straus
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

8.  Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells.

Authors:  D E Woods; D C Straus; W G Johanson; V K Berry; J A Bass
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.